Comparing Imperva (IMPV) & Its Rivals
Imperva (NASDAQ: IMPV) is one of 183 public companies in the “IT Services & Consulting” industry, but how does it contrast to its rivals? We will compare Imperva to similar companies based on the strength of its earnings, institutional ownership, dividends, profitability, valuation, analyst recommendations and risk.
Volatility and Risk
Imperva has a beta of 1.78, suggesting that its stock price is 78% more volatile than the S&P 500. Comparatively, Imperva’s rivals have a beta of 1.12, suggesting that their average stock price is 12% more volatile than the S&P 500.
97.0% of Imperva shares are owned by institutional investors. Comparatively, 63.0% of shares of all “IT Services & Consulting” companies are owned by institutional investors. 1.9% of Imperva shares are owned by company insiders. Comparatively, 16.5% of shares of all “IT Services & Consulting” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
This is a breakdown of current ratings and recommmendations for Imperva and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Imperva currently has a consensus target price of $51.33, suggesting a potential upside of 25.82%. As a group, “IT Services & Consulting” companies have a potential downside of 5.60%. Given Imperva’s higher possible upside, equities analysts plainly believe Imperva is more favorable than its rivals.
This table compares Imperva and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings & Valuation
This table compares Imperva and its rivals revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Imperva||$264.45 million||-$70.27 million||151.12|
|Imperva Competitors||$2.79 billion||$290.02 million||325.23|
Imperva’s rivals have higher revenue and earnings than Imperva. Imperva is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Imperva rivals beat Imperva on 7 of the 12 factors compared.
Imperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.